Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biocentis

Explore full profile

Genetic insect control solutions for agriculture and health

London, United KingdomFounded 2021Biotech & Life Sciences
Valuation $50–100M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Biocentis and the history behind them.

About Biocentis

Biocentis is a forward-thinking biotech company focused on pioneering innovative solutions in the realm of biological control. With a mission to create sustainable and environmentally friendly alternatives to traditional pest management, Biocentis harnesses the power of advanced biotechnologies to address some of the most pressing challenges in agriculture and public health.

Read full description

At the core of Biocentis' work is the development of cutting-edge biological control agents. These agents, derived from natural organisms, are designed to target and manage pest populations in a way that minimizes ecological disruption and promotes biodiversity. By leveraging the latest advancements in genetic engineering, microbiology, and molecular biology, Biocentis creates highly specific and effective biocontrol solutions that offer a safer alternative to chemical pesticides.

Biocentis' product portfolio includes a range of innovative biocontrol agents tailored to various applications. These products are rigorously tested to ensure their safety, efficacy, and environmental compatibility. By integrating these biocontrol agents into pest management strategies, Biocentis helps farmers, public health officials, and other stakeholders reduce their reliance on harmful chemicals and move towards more sustainable practices.

Collaboration and research are fundamental to Biocentis' approach. The company partners with leading research institutions, industry experts, and regulatory bodies to ensure that its solutions are based on the latest scientific knowledge and adhere to the highest standards of safety and efficacy. This collaborative spirit also extends to engaging with local communities and stakeholders to understand their needs and develop tailored solutions that address specific pest management challenges.

Biocentis is committed to ongoing innovation and the continuous improvement of its products and processes. The company invests heavily in research and development, exploring new technologies and methodologies to enhance the performance and sustainability of its biocontrol agents. This commitment to innovation positions Biocentis at the forefront of the biological control industry, driving forward the transition to more sustainable and environmentally responsible pest management practices.

In addition to its focus on product development, Biocentis places a strong emphasis on education and advocacy. The company actively works to raise awareness about the benefits of biological control and the importance of sustainable pest management. Through outreach programs, educational initiatives, and partnerships with advocacy groups, Biocentis seeks to inspire a broader movement towards more eco-friendly agricultural and public health practices.

Ultimately, Biocentis aims to transform the way we approach pest management, offering innovative, effective, and sustainable solutions that protect both human health and the environment. By championing the use of biological control agents and promoting a shift towards more sustainable practices, Biocentis is helping to build a healthier, more resilient future for our planet.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
London, United Kingdom
Employees
25
Open positions
None listed
Dealroom signal
88.7/100
Industry
Health
Sub-industry
BioTechnology, AgriTech
Sector
Biotech & Life Sciences, Biotechnology, Crop Protection, Infections and Infectious Diseases, Pest Control, Spinout, Sustainable Development Goals, Regenerative Agriculture, Climate Tech
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Nov 2025 $6M — Wellcome Trust ↗
SEED✓Equity / VC Nov 2025 $13M $52M Grantham Foundation · Algebris Investments ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Biocentis website traffic

Latest recorded traffic for Biocentis is 1.1K monthly website visits, up 511.1% over the last three months. Biocentis's team grew 25% over the past year.

Latest monthly visits1.1K 3-month web change+511.1% 1-year team growth+25%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • Neurone
  • Global Agri-Food Advancement Partnership
  • Wellcome Trust
  • Grantham Foundation
  • Algebris Investments

Other known investors2 additional known investors

  • College of Medicine and Integrated Health
  • Imperial College London
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇮🇹 Italy73.1%
🇬🇧 United Kingdom11.5%
🇺🇸 United States7.7%
🇱🇺 Luxembourg3.9%
🇬🇷 Greece3.9%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Biocentis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Biocentis’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.